Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GM vs GSK✓SelectedUSD · GSKGM vs GSK performance historyLatest closeAs of+0.45%11/17
Stock and ETF performance explorer

GM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+231.8%
GSK return
+170.8%
Excess return
+61.1%
Maximum drawdown
-60.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.5%-2.3%+2.8%+1.5%
7D-5.2%-3.0%-2.2%-4.0%
30D+0.1%+0.4%-0.2%-0.2%
3M-0.2%-1.2%+1.0%-0.1%
6M+12.8%+0.9%+11.8%+11.4%
YTD+4.0%+4.0%0.0%+0.9%
1Y+24.8%+7.3%+17.5%+19.3%
3Y+209.0%+57.1%+151.9%+134.4%
5Y+35.7%+43.0%-7.2%+5.9%
10Y+203.2%+103.1%+100.2%+88.5%
All+231.8%+170.8%+61.1%+59.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling